Analysis modules included computing genome-wide genetic correlations, inferring causality between AAA and the traits by bidirectional Mendelian randomization, identifying shared causal variants, genes and pathways, discovering tissues and cell being impacted the most by the shared signals, and prioritizing drugs for treating AAA comorbidities. CMD: cardiometabolic diseases, MT: metabolic traits.
